Literature DB >> 16014208

[Epidemiology and gallstones].

Torben Jørgensen1.   

Abstract

Gallstones are more frequent in women than in men due to pregnancy. Increasing age, familial history of the disease, unhealthy lifestyle, overweight, dyslipidemia, type 2 diabetes and high plasma insulin levels are all associated with gallstones. Few asymptomatic stones develop complications. Asymptomatic gallstones should not be treated, but there are difficulties in delimiting the symptoms that are specific to gallstones, and persistent pain after cholecystectomy is frequent. The introduction of laparoscopic cholecystectomy has led to an increase in the cholecystectomy rate and greater regional variation.

Entities:  

Mesh:

Year:  2005        PMID: 16014208

Source DB:  PubMed          Journal:  Ugeskr Laeger        ISSN: 0041-5782


  4 in total

1.  Assessment of characteristics of patients with cholelithiasis from economically deprived rural Karachi, Pakistan.

Authors:  Muhammad Naeem; Nasir Ali Rahimnajjad; Muhammad Kazim Rahimnajjad; Madiha Khurshid; Qazi Jalaluddin Ahmed; Syed Mariam Shahid; Faiza Khawar; Molham Mustafa Najjar
Journal:  BMC Res Notes       Date:  2012-06-28

2.  Gallbladder gallstone disease is associated with newly diagnosed coronary artery atherosclerotic disease: a cross-sectional study.

Authors:  Zhao-Yan Jiang; Xia Sheng; Chen-Ying Xu; Wei-Wei Li; Xian-Xing Chang; Lu-Ying Sun; Xiao-Bo Yang; Li-Fen Yu
Journal:  PLoS One       Date:  2013-09-18       Impact factor: 3.240

3.  Prevalence of Gall Bladder Stones among Type 2 Diabetic Patients in Benghazi Libya: A Case-control Study.

Authors:  Rr Elmehdawi; Sj Elmajberi; A Behieh; A Elramli
Journal:  Libyan J Med       Date:  2009-03-01       Impact factor: 1.657

4.  Abdominal regional fat distribution on MRI correlates with cholecystolithiasis.

Authors:  Yang Zhang; Tian Wu Chen; Xiao Ming Zhang; Yi-Xiang Wang; Xiao Xiao Chi; Xing Hui Li; Xiao Feng Gao; Yi Fan Ji
Journal:  PLoS One       Date:  2014-10-13       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.